Moutih Rafei

Publications

• Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy
  Molecules (Basel, Switzerland). Jun, 2022  |   Pubmed ID: 35744930
• LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a DsRNA Stress Response
  Cells. 06, 2022  |   Pubmed ID: 35681511
• Promoting Antigen Escape from Dendritic Cell Endosomes Potentiates Anti-tumoral Immunity
  Cell Reports. Medicine. Mar, 2022  |   Pubmed ID: 35492876
• Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
  Cells. 02, 2022  |   Pubmed ID: 35203247
• UM171A-induced ROS Promote Antigen Cross-presentation of Immunogenic Peptides by Bone Marrow-derived Mesenchymal Stromal Cells
  Stem Cell Research & Therapy. 01, 2022  |   Pubmed ID: 35012668
• Bone Marrow Aspirate Concentrate Versus Platelet-rich Plasma for Treating Knee Osteoarthritis: a One-year Non-randomized Retrospective Comparative Study
  BMC Musculoskeletal Disorders. Jan, 2022  |   Pubmed ID: 34980045
• Engineering Immunoproteasome-expressing Mesenchymal Stromal Cells: A Potent Cellular Vaccine for Lymphoma and Melanoma in Mice
  Cell Reports. Medicine. 12, 2021  |   Pubmed ID: 35028603
• Cell Therapy: Types, Regulation, and Clinical Benefits
  Frontiers in Medicine. 2021  |   Pubmed ID: 34881261
• Autologous BMAC Therapy Improves Spinal Degenerative Joint Disease in Lower Back Pain Patients
  Frontiers in Medicine. 2021  |   Pubmed ID: 33816523
• FcεR1-expressing Nociceptors Trigger Allergic Airway Inflammation
  The Journal of Allergy and Clinical Immunology. 06, 2021  |   Pubmed ID: 33453289
• TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
  Molecular Cancer Therapeutics. 01, 2021  |   Pubmed ID: 33087510
• Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity Cross-Priming of Endogenous Dendritic Cells
  Frontiers in Immunology. 2020  |   Pubmed ID: 33542714
• Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal
  IScience. Nov, 2020  |   Pubmed ID: 33103068
• A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties
  Frontiers in Pharmacology. 2020  |   Pubmed ID: 32231565
• Mesenchymal Stem Cells Beyond Regenerative Medicine
  Frontiers in Cell and Developmental Biology. 2020  |   Pubmed ID: 32133358
• Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function
  Frontiers in Immunology. 2019  |   Pubmed ID: 31552057
• Heart Failure Drug Proscillaridin A Targets MYC Overexpressing Leukemia Through Global Loss of Lysine Acetylation
  Journal of Experimental & Clinical Cancer Research : CR. Jun, 2019  |   Pubmed ID: 31196146
• Restoring Thymic Function: Then and Now
  Cytokine. 08, 2019  |   Pubmed ID: 31108430
• Interleukin-21 Promotes Thymopoiesis Recovery Following Hematopoietic Stem Cell Transplantation
  Journal of Hematology & Oncology. 06, 2017  |   Pubmed ID: 28615039
• Inflammatory Monocytes Promote Progression of Duchenne Muscular Dystrophy and Can Be Therapeutically Targeted Via CCR2
  EMBO Molecular Medicine. Oct, 2014  |   Pubmed ID: 25312642
• Ex Vivo Generation of Murine IL-10-producing B Cells by Fusokines
  Methods in Molecular Biology (Clifton, N.J.). 2014  |   Pubmed ID: 25015277
• Interleukin-21 Accelerates Thymic Recovery from Glucocorticoïd-induced Atrophy
  PloS One. 2013  |   Pubmed ID: 24023776
• Differential Effects of γc Cytokines on Postselection Differentiation of CD8 Thymocytes
  Blood. Jan, 2013  |   Pubmed ID: 23043071
• Inducible IL10(+) Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2012  |   Pubmed ID: 28157533
• Inducible IL10(+) Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2012  |   Pubmed ID: 22760541
• A MCP1 Fusokine with CCR2-specific Tumoricidal Activity
  Molecular Cancer. Sep, 2011  |   Pubmed ID: 21943176
• Development and Function of Innate Polyclonal TCRalphabeta+ CD8+ Thymocytes
  Journal of Immunology (Baltimore, Md. : 1950). Sep, 2011  |   Pubmed ID: 21844388
• A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Jul, 2010  |   Pubmed ID: 28178447
• A CCL2-based Fusokine As a Novel Biopharmaceutical for the Treatment of CCR2-driven Autoimmune Diseases
  Critical Reviews in Immunology. 2010  |   Pubmed ID: 21083526
• A Dendritic Cell Population Generated by a Fusion of GM-CSF and IL-21 Induces Tumor-antigen-specific Immunity
  Journal of Immunology (Baltimore, Md. : 1950). Dec, 2010  |   Pubmed ID: 21076067
• A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Ralpha Chain with Immune Activating and Tumoricidal Effects in Vivo
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Jul, 2010  |   Pubmed ID: 20389285
• [A Chimeric Cytokine to Help Autoimmune Diseases]
  Medecine Sciences : M/S. Feb, 2010  |   Pubmed ID: 20188040
• GIFT15 Fusokine to Foil Immunity's Follies
  Immunotherapy. Nov, 2009  |   Pubmed ID: 20635907
• A Granulocyte-macrophage Colony-stimulating Factor and Interleukin-15 Fusokine Induces a Regulatory B Cell Population with Immune Suppressive Properties
  Nature Medicine. Sep, 2009  |   Pubmed ID: 19668193
• Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Oct, 2009  |   Pubmed ID: 19602999
• An Engineered GM-CSF-CCL2 Fusokine is a Potent Inhibitor of CCR2-driven Inflammation As Demonstrated in a Murine Model of Inflammatory Arthritis
  Journal of Immunology (Baltimore, Md. : 1950). Aug, 2009  |   Pubmed ID: 19592643
• Characterization of Gaucher Disease Bone Marrow Mesenchymal Stromal Cells Reveals an Altered Inflammatory Secretome
  Blood. Oct, 2009  |   Pubmed ID: 19587377
• Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-dependent Manner
  Journal of Immunology (Baltimore, Md. : 1950). May, 2009  |   Pubmed ID: 19414750
• Autologous Bone Marrow Stromal Cells Genetically Engineered to Secrete an Igf-I Receptor Decoy Prevent the Growth of Liver Metastases
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Jul, 2009  |   Pubmed ID: 19367255
• Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine
  Journal of Immunology (Baltimore, Md. : 1950). Mar, 2009  |   Pubmed ID: 19234156
• Mesenchymal Stromal Cells Engineered to Express Erythropoietin Induce Anti-erythropoietin Antibodies and Anemia in Allorecipients
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2009  |   Pubmed ID: 19088705
• Mesenchymal Stromal Cell-derived CCL2 Suppresses Plasma Cell Immunoglobulin Production Via STAT3 Inactivation and PAX5 Induction
  Blood. Dec, 2008  |   Pubmed ID: 18812467
• A GMCSF and IL-15 Fusokine Leads to Paradoxical Immunosuppression in Vivo Via Asymmetrical JAK/STAT Signaling Through the IL-15 Receptor Complex
  Blood. Mar, 2007  |   Pubmed ID: 17082320